Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FES PET/MRI for Occult Disease in Lobular Breast Cancer
NCT07910474Phase 4Not yet recruiting
- Sponsor
- University of Wisconsin–Madison
- Start
- Nov 2026
- Primary completion
- Nov 2028
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in invasive lobular carcinoma (ILC), sponsored by University of Wisconsin–Madison. Primary endpoint: Percent of Participants where Disease is Detected using 18F-FES-PET/MRI at 6 months. Planned start Nov 2026; status: not yet recruiting.
02
Conditions
invasive lobular carcinoma (ILC)
Beyond the preview
Go deeper on NCT07910474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07910474.